Comparative evaluation of the inhibitory effects of aspirin-like drugs on prostaglandin production by human platelets and synovial tissue.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001241:Aspirin / Q000494:pharmacology*; D001792:Blood Platelets / Q000201:enzymology*; D016861:Cyclooxygenase Inhibitors; D005260:Female; D005279:Fenoprofen / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D010666:Phenylpropionates / Q000494:pharmacology*; D011460:Prostaglandins F / Q000096:biosynthesis; D013583:Synovial Membrane / Q000201:enzymology*
D016861:Cyclooxygenase Inhibitors; D010666:Phenylpropionates; D011460:Prostaglandins F; D006899:Mixed Function Oxygenases; D001241:Aspirin; D005279:Fenoprofen; D006854:Hydrocortisone; D007213:Indomethacin